Regulatory S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation-Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD OncLive PodcastWelcome to OncLive On Air !RegulatoryOncologyRead full story pharminent March 31, 2026 (Last updated: April 1, 2026) OncLive Podcast Welcome to OncLive On Air ! RegulatoryOncologyRead full story Post navigation Previous: Novo hits back at rivals with cut-price Wegovy subscriptionsNext: NHS to offer Wegovy to a million more people in England Related Stories Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026 Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026 Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
